Browsing Institutt for helse og samfunn by Author "Regan, Catherine"
Now showing items 1-4 of 4
-
Burger, Emily; Portnoy, Allison; Campos, Nicole G.; Sy, Stephen; Regan, Catherine; Kim, Jane J (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)The human papillomavirus (HPV) vaccines may provide some level of cross‐protection against high‐risk HPV genotypes not directly targeted by the vaccines. We evaluated the long‐term health and economic impacts of routine ...
-
Burger, Emily; de Kok, Inge; Groene, Emily; Killen, Jame; Canfell, Karen; Kulasingam, Shalini; Kuntz, Karen; Matthijsse, Suzette; Regan, Catherine; Simms, Kate; Sy, Stephen; Alarid-Escudero, Fernando; Vaidyanathan, V; van Ballegooijen, Marjolein; Kim, Jane J (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2019)The natural history of human papillomavirus (HPV)-induced cervical cancer (CC) is not directly observable, yet the age of HPV acquisition and duration of preclinical disease (dwell time) influences the effectiveness of ...
-
Kim, Jane J; Simms, Kate T; Killen, James; Smith, Megan A; Burger, Emily; Sy, Stephen; Regan, Catherine; Canfell, Karen (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)Background A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for women and men aged 30 to 45 ...
-
Kim, Jane J; Burger, Emily; Regan, Catherine; Sy, Stephen (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (hrHPV) testing is needed to inform guidelines. Objective: To inform the US Preventive Services Task Force by modeling the ...